Literature DB >> 17765294

Altered detection of molecules associated with leukocyte traffic in HUVECs derived from newborns with a strong family history of myocardial infarction.

Araceli Paez1, Emma Rodriguez, Erika Rendon, Elvira Varela, Teresa Fortoul, Blanca Espinosa, Felipe Masso, Jorge Guevara, Luis F Montaño.   

Abstract

Atherosclerosis is a chronic inflammatory disease. As such, recruitment of immune cells is a significant event. Tightly controlled signaling molecules regulate leukocyte adhesion and migration to the tissues. The aim of this study was to determine if human umbilical vein endothelial cells (HUVECs) derived from healthy newborns with a strong family history of myocardial infarction (FHMI) showed variations in the presence of molecules related with leukocyte traffic and migration, in comparison to control healthy newborns. For this purpose, we evaluated the labeling of sialic acid containing glycoproteins, tight junction claudins and the cytoskeleton, using lectin- and immunocytochemistry in HUVECs from individuals with and without a strong FHMI. Our results show important differences in the labeling of alpha-2,3 or alpha-2,6 sialic acid-containing glycoconjugates, a disarrangement of actin filaments secondary to the absence of cytoplasmic claudin-5 immunopositivity and an increase in the binding of FHMI HUVECs to CD3+ Jurkat cells. It is possible that these differences relate to a predisposition for early appearance of atherosclerotic lesions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17765294     DOI: 10.1016/j.acthis.2007.05.007

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  1 in total

1.  Characterization of immortalized human dermal microvascular endothelial cells (HMEC-1) for the study of HDL functionality.

Authors:  Mónica Muñoz-Vega; Felipe Massó; Araceli Páez; Elizabeth Carreón-Torres; Hector A Cabrera-Fuentes; José Manuel Fragoso; Nonanzit Pérez-Hernández; Laurent O Martinez; Souad Najib; Gilberto Vargas-Alarcón; Óscar Pérez-Méndez
Journal:  Lipids Health Dis       Date:  2018-03-09       Impact factor: 3.876

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.